NEW ZEALAND GAZETTE, No. 73

28 APRIL 2005

1733

Departmental Notices

Agriculture and Forestry

Agricultural Compounds and Veterinary Medicines Act 1997

Notice of Application to Register a Trade Name Product (Notice No. 1418)

Pursuant to section 14 (1) of the Agricultural Compounds and Veterinary Medicines Act 1997, the Director-General of the Ministry of Agriculture and Forestry hereby gives notice that the following application has been made to register a trade name product under section 9 (1) of the Agricultural Compounds and Veterinary Medicines Act 1997:

Trade Name: Equip F
Reference: A009522
Active Ingredients and Concentrations:

• Haemaglutinin of equine influenza A/Equi/1 Newmarket/77 10 – 11 µg
• Haemaglutinin of equine influenza A/Equi/2 Borlange ’91 20 – 22 µg
• Haemaglutinin of equine influenza A/Equi/2 Kentucky ’98 1.40 – 1.54 µg

General Use Claim: For the active immunisation of healthy horses and ponies to reduce clinical signs of equine influenza and reduce virus shedding.

Any person may make a written submission to the Director-General, under section 17 of the Agricultural Compounds and Veterinary Medicines Act 1997, concerning any application notified above.

Such submissions:

(a) must state in full the reasons for making the submission;
(b) may state any decision sought on that application;
(c) must be received by the Director-General no later than 30 working days after the date of notification in the New Zealand Gazette; and
(d) should be forwarded to the address given below.

A copy of every submission will be forwarded to the applicant for their information.

The address below is:

(a) where submissions and requests for copies of the public information relating to the application can be sent;
(b) where the public information relating to the application can be viewed; and
(c) the Director-General’s address for service:
ACVM Group, New Zealand Food Safety Authority, Ministry of Agriculture and Forestry, 68-86 Jervois Quay
(P.O. Box 2835), Wellington.

The applicant’s address for service is:
Biosecurity New Zealand, ASB Bank House, 101-103 The Terrace, Wellington.

Dated at Wellington this 22nd day of April 2005.

MAREE ZINZLEY, Programme Manager (Operations) (acting under delegated authority).

go2540

Notice of Application to Register Trade Name Products (Notice No. 1419)

Pursuant to section 14 (1) of the Agricultural Compounds and Veterinary Medicines Act 1997, the Director-General of the Ministry of Agriculture and Forestry hereby gives notice that the following application has been made to register trade name products under section 9 (1) of the Agricultural Compounds and Veterinary Medicines Act 1997:

Trade Name: Prilium 150 MG
Reference: A009527
Active Ingredients and Concentrations: Imidapril HCL 170 g/kg as freeze dried powder or 5 g/L reconstituted solution
General Use Claim: In dogs and cats: Treatment of heart failure of stages II, III and IV according to the NYHA classification, caused by mitral regurgitation or by dilated cardiomyopathy.

Trade Name: Prilium 300 MG
Reference: A009528
Active Ingredients and Concentrations: Imidapril HCL 300 g/kg as freeze dried powder or 10 g/L reconstituted solution
General Use Claim: In dogs and cats: Treatment of heart failure of stages II, III and IV according to the NYHA classification, caused by mitral regurgitation or by dilated cardiomyopathy.

Trade Name: Prilium 75 MG
Reference: A009529
Active Ingredients and Concentrations: Imidapril HCL 300 g/kg as freeze dried powder or 10 g/L reconstituted solution
General Use Claim: In dogs and cats: Treatment of heart failure of stages II, III and IV according to the NYHA classification, caused by mitral regurgitation or by dilated cardiomyopathy.